MedTrace Logo

I-ASV in Cardiac Surgery

NCT06178510 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 328

Last updated 2024-11-04

No results posted yet for this study

Summary

'POStoperative INTELLiVENT-adaptive support VEntilation in cardiac surgery patients II (POSITiVE II) is an investigator-initiated, international, multicenter, parallel, randomized clinical trial in patients after cardiac surgery.

Conditions

  • Ventilator Lung

Interventions

DEVICE

INTELLiVENT-ASV.

INTELLiVENT-ASV® is a closed-loop ventilation mode that automatically adjusts respiratory rate and tidal volume according to the oxygen and ventilatory patient needs

Sponsors & Collaborators

  • University Hospital Dubrava

    collaborator OTHER

  • Università degli Studi dell'Insubria

    collaborator UNKNOWN

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER

  • University of Zurich

    collaborator OTHER

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Edda Tschernko, MD · Medical University of Vienna

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-31
Primary Completion
2025-06-30
Completion
2025-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06178510 on ClinicalTrials.gov